MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23
NEWS RELEASE10 AUGUST 2023, 4PM ET / 22:00 CET MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23 Company to Host Conference Call with Live Q&A, August 23, 2023 at 4:30pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – August 10, 2023 – MDxHealth SA […]
Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test
NEWS RELEASE9 AUGUST 2023, 4PM ET / 22:00 CET Cigna Expands Commercial and Medicare AdvantageCoverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test Expansion of coverage with Cigna now includes full menu of Company’s precision diagnostic prostate cancer tests, representing more than 15 million lives under coverage IRVINE, CA, and HERSTAL, BELGIUM […]
MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting
NEWS RELEASE – REGULATED INFORMATION 30 June 2023, 10:00 p.m. CEST MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting IRVINE, CA, and HERSTAL, BELGIUM – 30 June 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today held an extraordinary general shareholders’ meeting (“EGM“). The items […]
MDxHealth Announces its Extraordinary General Shareholders’ Meeting
NEWS RELEASE – REGULATED INFORMATION JUNE 5, 2023, 5:30 pm ET/ 23:30 CEST MDxHealth Announces its Extraordinary General Shareholders’ Meeting IRVINE, CA, and HERSTAL, BELGIUM – June 5, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the “Company” or “mdxhealth“), a commercial-stage precision diagnostics company, today invites the holders of securities issued […]
MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATION 25 May 2023, 22:30 CET MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings IRVINE, CA, and HERSTAL, BELGIUM – 25 May 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today held its ordinary annual general shareholders’ meeting (“AGM“) […]
MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference
NEWS RELEASEMay 23, 2023, 4PM ET/ 22:00 CET MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference IRVINE, CA, and HERSTAL, BELGIUM – May 23, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics company, today announced that Michael McGarrity, Chief Executive Officer, will present […]
MDxHealth Reports Q1-2023 Results
NEWS RELEASE – REGULATED INFORMATION15 MAY 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Q1-2023 Results Year-over-year revenues increase by 141% to $14.7 million; excluding GPS, revenues up 39% Gross margin expanded by 1,270 basis points over prior year period Positive Local Coverage Determination (LCD), extending coverage for Select mdx test to Medicare […]
MDxHealth to Present First Quarter 2023 Financial Results on May 15
NEWS RELEASE 1 MAY 2023, 4PM ET / 22:00 CET MDxHealth to Present First Quarter 2023 Financial Results on May 15 Company to Host Conference Call with Live Q&A, May 15, 2023 at 4:30pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – May 1, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision […]
MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATIONAPRIL 25, 2023, 4:00 pm ET/ 22:00 CET IRVINE, CA, and HERSTAL, BELGIUM – April 25, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the “Company” or “mdxhealth“), a commercial-stage precision diagnostics company, today invites the holders of securities issued by the Company to its ordinary and extraordinary general shareholders’ […]
Foundational LCD Covers Select mdx for Prostate Cancer
NEWS RELEASE – INSIDE INFORMATIONApril 19, 2023, 4:00PM EDT / 22:00 CET IRVINE, CA, and HERSTAL, BELGIUM – April 19, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, received notice that its Select mdx for Prostate Cancer test has successfully completed a rigorous technical assessment process with the Molecular Diagnostics Services (MolDX) […]
